Expert Review Of Anticancer Therapy impact factor, indexing, ranking (2024)


expert

Aim and Scope

The Expert Review Of Anticancer Therapy is a research journal that publishes research related to Medicine. This journal is published by the Taylor and Francis Ltd.. The ISSN of this journal is 14737140, 17448328. Based on the Scopus data, the SCImago Journal Rank (SJR) of expert review of anticancer therapy is 0.841.

Also, please check the following important details about expert review of anticancer therapy: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Expert Review Of Anticancer Therapy Ranking

Impact Factor: 2.9
5-Year JIF: 4
SJR (SCImago Journal Rank): 0.841
Quartile: Q2

The latest Impact Factor list (JCR) is released in June 2024.

The Impact Factor of Expert Review Of Anticancer Therapy is 2.9.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.


Important Metrics

Journal Title: Expert Review of Anticancer Therapy
Publisher: Taylor and Francis Ltd.
ISSN: 14737140, 17448328
Type: journal
Journal Scope: Medicine
Country: United Kingdom
H-Index: 79
SJR: 0.841
Quartile: Oncology (Q2); Pharmacology (medical) (Q2)

Indexing

The expert review of anticancer therapy is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Expert Review Of Anticancer Therapy Impact Factor 2024

The latest impact factor of expert review of anticancer therapy is 2.9 which is recently updated in June, 2024.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.


Quartile

The latest Quartile of expert review of anticancer therapy is Q2.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.


Journal Publication Time

The publication time may vary depending on factors such as the complexity of the research and the current workload of the editorial team. Journals typically request reviewers to submit their reviews within 3-4 weeks. However, some journals lack mechanisms to enforce this deadline, making it difficult to predict the duration of the peer review process.

The review time also depends upon the quality of the research paper.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Expert Review Of Anticancer Therapy?

If your research is related to Medicine, then visit the official website of expert review of anticancer therapy and send your manuscript.

Tips for publishing in Expert Review Of Anticancer Therapy:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

  • The impact factor of expert review of anticancer therapy is 2.9.
  • The expert review of anticancer therapy is a reputed research journal.
  • It is published by Taylor and Francis Ltd..
  • The journal is indexed in UGC CARE, Scopus, SCIE, PubMed.
  • The (SJR) SCImago Journal Rank is 0.841.

Sources: expert review of anticancer therapy







SIMILIAR JOURNALS


DENTAL AND MEDICAL PROBLEMS

ISSN: 1644-387X
Publisher: WROCLAW MEDICAL UNIV

RESUSCITATION PLUS

ISSN: 2666-5204
Publisher: ELSEVIER

WORLD JOURNAL OF TRADITIONAL CHINESE MEDICINE

ISSN: 2311-8571
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONS

AMERICAN JOURNAL OF CHINESE MEDICINE

ISSN: 0192-415X
Publisher: WORLD SCIENTIFIC PUBL CO PTE LTD

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

ISSN: 1350-6129
Publisher: TAYLOR & FRANCIS LTD

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

ISSN: 1084-9785
Publisher: MARY ANN LIEBERT, INC

CURRENT MEDICAL RESEARCH AND OPINION

ISSN: 0300-7995
Publisher: TAYLOR & FRANCIS LTD

DENTOMAXILLOFACIAL RADIOLOGY

ISSN: 0250-832X
Publisher: BRITISH INST RADIOLOGY

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

ISSN: 0014-2972
Publisher: WILEY

INDIAN JOURNAL OF MEDICAL RESEARCH

ISSN: 0971-5916
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONS

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.